Key Takeaways
- • Iron Path Capital has acquired Boulder Scientific Company from Quad-C Management, marking the first investment from its $450 million Iron Path Capital Fund II.
- • Terms of the transaction were not disclosed.
- • Boulder Scientific is a Longmont, Colorado manufacturer of organometallic compounds and complex synthetic chemistry capabilities, operating two facilities in Colorado and serving polyolefin, microelectronics, semiconductor, pharmaceutical, and aerospace and defense customers.
- • Iron Path describes the deal as a strategic partnership with management to support the company's next phase of growth, including expansion into existing and new end markets.
Summary
Iron Path Capital, a private equity firm focused on specialty chemicals and materials, engineered products and solutions, and technical services selling into highly regulated end markets, announced the acquisition of Boulder Scientific Company from Quad-C Management, according to a Business Wire release dated November 11, 2026. The acquisition is the first investment from Iron Path Capital Fund II, a $450 million partnership. Terms of the transaction were not disclosed.
Boulder Scientific, headquartered in Longmont, Colorado and incorporated in 1961, is a manufacturer of high-performance organometallic compounds and a provider of complex synthetic chemistry capabilities. Its products are used mainly as metallocene catalysts in polyolefin production, and the company also supplies activators, ligands, air- and moisture-sensitive compounds, pyrophoric materials and other co-catalysts. Customers span the polyolefin, microelectronics, semiconductor, pharmaceutical, and aerospace and defense industries in the United States and internationally. The company operates two sites in Colorado.
Rob Reistetter, Managing Partner at Iron Path Capital, said the firm's strategy is to partner with technical companies that have unique capabilities and described Boulder Scientific as a differentiated, technically driven business. He said Iron Path looks forward to supporting continued investment in the company's capabilities and expansion into existing and new end markets.
Rich Preziotti, CEO of Boulder Scientific, said the company's growth plans in advanced catalysts, electronics, aerospace and defense, and life sciences would be enhanced through collaboration with Iron Path and the resources available to support continued growth.
Iron Path Capital describes itself as an operationally focused private equity firm targeting specialized and technical lower middle market businesses, with offices in Nashville, Tennessee, and Charlottesville, Virginia.
Boulder Scientific, headquartered in Longmont, Colorado and incorporated in 1961, is a manufacturer of high-performance organometallic compounds and a provider of complex synthetic chemistry capabilities. Its products are used mainly as metallocene catalysts in polyolefin production, and the company also supplies activators, ligands, air- and moisture-sensitive compounds, pyrophoric materials and other co-catalysts. Customers span the polyolefin, microelectronics, semiconductor, pharmaceutical, and aerospace and defense industries in the United States and internationally. The company operates two sites in Colorado.
Rob Reistetter, Managing Partner at Iron Path Capital, said the firm's strategy is to partner with technical companies that have unique capabilities and described Boulder Scientific as a differentiated, technically driven business. He said Iron Path looks forward to supporting continued investment in the company's capabilities and expansion into existing and new end markets.
Rich Preziotti, CEO of Boulder Scientific, said the company's growth plans in advanced catalysts, electronics, aerospace and defense, and life sciences would be enhanced through collaboration with Iron Path and the resources available to support continued growth.
Iron Path Capital describes itself as an operationally focused private equity firm targeting specialized and technical lower middle market businesses, with offices in Nashville, Tennessee, and Charlottesville, Virginia.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.